Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $15,526.48 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.7458
Revenue (TTM): $2.98 M
Dividend Yield: N/A%
ROE: -206.74%
Latest News
-
BridgeBio Pharma Launches Secondary Public Offering Of 5M Shares Of Common Stock By Selling Stockholder KKR Genetic Disorder L.P
Thu, Aug 13, 2026 5:46 PM
-
Truist Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $107
Wed, Aug 12, 2026 1:20 PM
-
Canaccord Genuity Maintains Buy on BridgeBio Pharma, Raises Price Target to $106
Wed, Aug 12, 2026 11:42 AM
-
JP Morgan Maintains Overweight on BridgeBio Pharma, Raises Price Target to $111
Wed, Aug 12, 2026 10:00 AM
-
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months
Tue, Aug 11, 2026 12:49 PM
-
B of A Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $104
Tue, Aug 11, 2026 12:44 PM
-
TD Cowen Maintains Buy on BridgeBio Pharma, Raises Price Target to $110
Tue, Aug 11, 2026 11:50 AM
-
Morgan Stanley Maintains Overweight on BridgeBio Pharma, Lowers Price Target to $97
Tue, Aug 11, 2026 11:45 AM
-
BridgeBio Pharma (NASDAQ:BBIO) Flashes Perfect Technical Score and Tight Breakout Setup
Tue, Aug 11, 2026 10:31 AM
-
Piper Sandler Maintains Overweight on BridgeBio Pharma, Raises Price Target to $115
Tue, Aug 11, 2026 9:14 AM
Key Financials
Financial data not available
